Elanco Animal Health Management

Management Kriterienprüfungen 3/4

Elanco Animal Health CEO ist Jeff Simmons , ernannt in Jul 2018, hat eine Amtszeit von 6.33 Jahren. Die jährliche Gesamtvergütung beträgt $13.66M , bestehend aus 8.8% Gehalt und 91.2% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.23% der Aktien des Unternehmens, im Wert von $14.92M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.9 Jahre bzw. 5.7 Jahre.

Wichtige Informationen

Jeff Simmons

Geschäftsführender

US$13.7m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts8.8%
Amtszeit als Geschäftsführer6.3yrs
Eigentum des Geschäftsführers0.2%
Durchschnittliche Amtszeit des Managements5.9yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder5.7yrs

Jüngste Management Updates

Recent updates

Elanco Animal Health's (NYSE:ELAN) Solid Profits Have Weak Fundamentals

Nov 15
Elanco Animal Health's (NYSE:ELAN) Solid Profits Have Weak Fundamentals

Elanco Animal Health: Not Expensive, But Debt Remains An Issue

Nov 08

Here's Why Elanco Animal Health (NYSE:ELAN) Has A Meaningful Debt Burden

Sep 22
Here's Why Elanco Animal Health (NYSE:ELAN) Has A Meaningful Debt Burden

Elanco Animal Health Incorporated (NYSE:ELAN) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Sep 01
Elanco Animal Health Incorporated (NYSE:ELAN) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Elanco Animal Health: Positioned For Success

Aug 16

Investors Don't See Light At End Of Elanco Animal Health Incorporated's (NYSE:ELAN) Tunnel And Push Stock Down 27%

Jul 11
Investors Don't See Light At End Of Elanco Animal Health Incorporated's (NYSE:ELAN) Tunnel And Push Stock Down 27%

Elanco Animal Health: Pipeline Concerns Appear Overblown

Jun 30

Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Jun 06
Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Elanco Animal Health: At Least Fully Valued After Rally

Jun 05

Benign Growth For Elanco Animal Health Incorporated (NYSE:ELAN) Underpins Its Share Price

Apr 22
Benign Growth For Elanco Animal Health Incorporated (NYSE:ELAN) Underpins Its Share Price

Elanco Animal Health (NYSE:ELAN) Seems To Be Using A Lot Of Debt

Feb 24
Elanco Animal Health (NYSE:ELAN) Seems To Be Using A Lot Of Debt

Elanco Animal Health: A Solid Sale Addresses Leverage

Feb 09

Elanco Animal Health Incorporated (NYSE:ELAN) Looks Inexpensive But Perhaps Not Attractive Enough

Jan 01
Elanco Animal Health Incorporated (NYSE:ELAN) Looks Inexpensive But Perhaps Not Attractive Enough

Elanco Animal Health: Turning More Healthy

Dec 21

Is Elanco Animal Health (NYSE:ELAN) A Risky Investment?

Nov 09
Is Elanco Animal Health (NYSE:ELAN) A Risky Investment?

Elanco Animal Health: Signs Of Stabilization, Amidst Still A Big Debt Pile

Oct 05

Here's Why Elanco Animal Health (NYSE:ELAN) Is Weighed Down By Its Debt Load

Aug 02
Here's Why Elanco Animal Health (NYSE:ELAN) Is Weighed Down By Its Debt Load

Elanco Animal Health: Seems Like A Decent Bet Right Now

Jul 25

Elanco Animal Health: Robust Results Overshadowed By Persisting Challenges

Jul 14

There's No Escaping Elanco Animal Health Incorporated's (NYSE:ELAN) Muted Revenues

Jun 09
There's No Escaping Elanco Animal Health Incorporated's (NYSE:ELAN) Muted Revenues

Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Feb 22
Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Elanco Q4 2022 Earnings Preview

Feb 20

Elanco's Tangible Equity Units: Living With The Worst Case

Dec 13

We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Nov 08
We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Elanco Q3 2022 Earnings Preview

Nov 07

Elanco Animal Health: This 'Sick Dog' Should Recover

Oct 19

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Jeff Simmons im Vergleich zu den Einnahmen von Elanco Animal Health verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

US$205m

Jun 30 2024n/an/a

-US$1b

Mar 31 2024n/an/a

-US$1b

Dec 31 2023US$14mUS$1m

-US$1b

Sep 30 2023n/an/a

-US$1b

Jun 30 2023n/an/a

-US$113m

Mar 31 2023n/an/a

-US$26m

Dec 31 2022US$13mUS$1m

-US$78m

Sep 30 2022n/an/a

-US$132m

Jun 30 2022n/an/a

-US$171m

Mar 31 2022n/an/a

-US$371m

Dec 31 2021US$12mUS$1m

-US$483m

Sep 30 2021n/an/a

-US$698m

Jun 30 2021n/an/a

-US$729m

Mar 31 2021n/an/a

-US$572m

Dec 31 2020US$9mUS$1m

-US$574m

Sep 30 2020n/an/a

-US$246m

Jun 30 2020n/an/a

-US$101m

Mar 31 2020n/an/a

-US$13m

Dec 31 2019US$16mUS$1m

US$68m

Sep 30 2019n/an/a

US$94m

Jun 30 2019n/an/a

US$144m

Mar 31 2019n/an/a

US$45m

Dec 31 2018US$5mUS$775k

US$87m

Sep 30 2018n/an/a

-US$91m

Jun 30 2018n/an/a

-US$172m

Mar 31 2018n/an/a

-US$174m

Dec 31 2017US$5mUS$688k

-US$311m

Vergütung im Vergleich zum Markt: JeffDie Gesamtvergütung ($USD13.66M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD7.94M).

Entschädigung vs. Einkommen: JeffDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


Geschäftsführer

Jeff Simmons (57 yo)

6.3yrs

Amtszeit

US$13,663,169

Vergütung

Mr. Jeffrey N. Simmons, also known as Jeff, serves as President and Chief Executive Officer at Elanco Animal Health Incorporated since July 2018 and its Director since September 2018. Mr. Simmons serves as...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Jeffrey Simmons
President6.3yrsUS$13.66m0.23%
$ 14.9m
Todd Young
Executive VP & CFO6yrsUS$3.73m0.035%
$ 2.3m
Ramiro Cabral
Executive Vice President of Elanco International6.3yrsUS$2.65m0.022%
$ 1.5m
Ellen de Brabander
Executive Vice President of Research3.1yrsUS$3.68m0.0097%
$ 635.6k
Timothy Bettington
Executive Vice President of Corporate Strategy & Market Development1.7yrsUS$2.19m0.017%
$ 1.1m
James Meer
Senior VP & Chief Accounting Officer6.2yrskeine Daten0.0054%
$ 357.9k
Chris Keeley
Senior VP & Chief Information Officerno datakeine Datenkeine Daten
David Kinard
Executive Vice President of Human Resources5.8yrsUS$2.85m0.024%
$ 1.5m
Katy Grissom
Head of Investor Relationsno datakeine Datenkeine Daten
Shiv O'Neill
Executive Vice President1.8yrskeine Daten0.0048%
$ 316.5k
Larbi Lier
Senior Vice President of Asiano datakeine Datenkeine Daten
Shabbir Simjee
Chief Medical Officerno datakeine Datenkeine Daten

5.9yrs

Durchschnittliche Betriebszugehörigkeit

53yo

Durchschnittliches Alter

Erfahrenes Management: ELANDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5.9 ).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Jeffrey Simmons
President6.2yrsUS$13.66m0.23%
$ 14.9m
William Doyle
Independent Director3.9yrsUS$330.01k0.0061%
$ 399.4k
Roy Hoover
Independent Director6.2yrsUS$496.01k0.060%
$ 3.9m
Paul Herendeen
Independent Director3.9yrsUS$330.01k0.0020%
$ 132.9k
Lawrence Kurzius
Independent Chairman6.2yrsUS$350.01k0.0020%
$ 132.9k
Art Garcia
Independent Director5.5yrsUS$330.01k0.00071%
$ 46.7k
Denise Scots-Knight
Independent Director5.7yrsUS$330.01kkeine Daten
John Paul Bilbrey
Independent Director5.7yrsUS$346.01k0.0084%
$ 555.3k
Deborah Kochevar
Independent Director5.7yrsUS$346.01k0.00020%
$ 13.2k
Kirk McDonald
Independent Director5.7yrsUS$330.01kkeine Daten
Michael Harrington
Independent Director6.2yrsUS$330.01k0.0040%
$ 260.6k
Kapila Anand
Independent Director6.2yrsUS$355.01k0.00065%
$ 42.8k

5.7yrs

Durchschnittliche Betriebszugehörigkeit

65.5yo

Durchschnittliches Alter

Erfahrener Vorstand: ELANDie Vorstandsmitglieder gelten als erfahren (5.7 Jahre durchschnittliche Amtszeit).